Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Nuvalent, Inc. (NUVL)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 65,769,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Nuvalent is a biopharmaceutical company. Co.'s product candidate, NVL-520, is a ROS proto-oncogene 1 (ROS1)-selective inhibitor designed with the aim to address the clinical challenges of emergent treatment resistance, central nervous system (CNS)-related adverse events, and brain metastases that may limit the use of available ROS1 tyrosine kinase inhibitors. Co.'s another product candidate, NVL-655, is a brain-penetrant anaplastic lymphoma kinase (ALK)-selective inhibitor, designed with the aim to address the clinical challenges of emergent treatment resistance, CNS-related adverse events, and brain metastases that may limit the use of first-, second-, and third-generation ALK inhibitors.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 799,253
Total Buy Value $0 $0 $0 $26,774,976
Total People Bought 0 0 0 2
Total Buy Transactions 0 0 0 2
Total Shares Sold 1,212,833 1,454,179 1,660,039 1,942,739
Total Sell Value $87,684,648 $105,784,257 $115,993,702 $123,872,796
Total People Sold 5 7 8 8
Total Sell Transactions 16 25 47 82
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 155
  Page 3 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Noci Darlene Chief Development Officer   •       –      –    2023-09-01 4 AS $46.12 $139,692 D/D (3,000) 0     -
   Noci Darlene Chief Development Officer   •       –      –    2023-09-01 4 OE $1.08 $3,240 D/D 3,000 3,000     -
   Miller Deborah Ann Chief Legal Officer   •       –      –    2023-08-15 4 AS $42.46 $85,310 D/D (2,000) 0     -
   Miller Deborah Ann Chief Legal Officer   •       –      –    2023-08-15 4 OE $6.89 $13,780 D/D 2,000 2,000     -
   Noci Darlene Chief Development Officer   •       –      –    2023-08-01 4 AS $49.69 $149,844 D/D (3,000) 0     -
   Noci Darlene Chief Development Officer   •       –      –    2023-08-01 4 OE $1.08 $3,240 D/D 3,000 3,000     -
   Balcom Alexandra Chief Financial Officer   •       –      –    2023-07-31 4 AS $48.61 $1,224,796 D/D (25,000) 0     -
   Balcom Alexandra Chief Financial Officer   •       –      –    2023-07-31 4 OE $1.08 $27,000 D/D 25,000 25,000     -
   Miller Deborah Ann Chief Legal Officer   •       –      –    2023-07-28 4 AS $48.52 $315,380 D/D (6,500) 0     -
   Miller Deborah Ann Chief Legal Officer   •       –      –    2023-07-28 4 OE $6.89 $44,785 D/D 6,500 6,500     -
   Turner Christopher Durant Chief Medical Officer   •       –      –    2023-07-28 4 AS $48.93 $130,398 D/D (2,665) 14,513     -
   Turner Christopher Durant Chief Medical Officer   •       –      –    2023-07-28 4 OE $6.89 $18,362 D/D 2,665 17,178     -
   Turner Christopher Durant Chief Medical Officer   •       –      –    2023-07-26 4 AS $46.85 $110,800 D/D (2,365) 14,513     -
   Turner Christopher Durant Chief Medical Officer   •       –      –    2023-07-26 4 OE $6.89 $16,295 D/D 2,365 16,878     -
   Turner Christopher Durant Chief Medical Officer   •       –      –    2023-07-24 4 AS $46.82 $9,364 D/D (200) 14,513     -
   Turner Christopher Durant Chief Medical Officer   •       –      –    2023-07-24 4 OE $6.89 $1,378 D/D 200 14,713     -
   Turner Christopher Durant Chief Medical Officer   •       –      –    2023-07-20 4 AS $46.80 $4,680 D/D (100) 14,513     -
   Turner Christopher Durant Chief Medical Officer   •       –      –    2023-07-20 4 OE $6.89 $689 D/D 100 14,613     -
   Noci Darlene Chief Development Officer   •       –      –    2023-07-20 4 AS $45.17 $494,205 D/D (10,941) 0     -
   Noci Darlene Chief Development Officer   •       –      –    2023-07-20 4 OE $1.08 $11,816 D/D 10,941 10,941     -
   Noci Darlene Chief Development Officer   •       –      –    2023-07-19 4 AS $45.04 $205,337 D/D (4,559) 0     -
   Noci Darlene Chief Development Officer   •       –      –    2023-07-19 4 OE $1.08 $4,924 D/D 4,559 4,559     -
   Miller Deborah Ann Chief Legal Officer   •       –      –    2023-07-17 4 AS $41.19 $86,123 D/D (2,000) 0     -
   Miller Deborah Ann Chief Legal Officer   •       –      –    2023-07-17 4 OE $6.89 $13,780 D/D 2,000 2,000     -
   Noci Darlene Chief Development Officer   •       –      –    2023-07-03 4 AS $41.33 $124,427 D/D (3,000) 0     -
  155 Records found
  1  2  3  4  5  6  7   
  Page 3 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us